Trial intelligence / Profile preview

Modafinil for Cancer Related Fatigue in Patients Undergoing Radiation Therapy

NCT01440621Phase 3Completed

Sponsor
Indira Gandhi Medical College and Hospital
Start
Aug 2010
Primary completion
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in cancer-related fatigue (CRF) comparing Modafinil with Placebo (2 arms). Primary endpoint: Reduction in Cancer Related Fatigue at 12 weeks. Started Aug 2010; status: completed.

02

Drugs

modafinil
03

Conditions

cancer-related fatigue (CRF)

Beyond the preview

Go deeper on NCT01440621.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01440621.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call